Award recordCONTRACT

NOVARTIS PHARMACEUTICALS CORPORATION

PIID 36C24226N0216· VHA· 242-NETWORK CONTRACT OFFICE 02 (36C242)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $813,476 net obligations· UEI NG61ZA8TADW3· NJ

Description

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

First action · last action
2025-10-28 · 2026-02-06
Transactions
2
First transaction's obligation
$299,062
Base + all options value (sum of deltas)
$813,476
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0180
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$813,476$0Base award · 2025-10-28 · this action $299,062 · running total $299,062Modification P00001 · 2026-02-06 · this action $514,414 · running total $813,476
  • Base2025-10-28+$299,062= $299,062
  • Mod P000012026-02-06+$514,414= $813,476
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-10-28+$299,062$299,062PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-02-06+$514,414$813,476PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NG61ZA8TADW3)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0394255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$891,651FY2026
36C26226F0314262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$823,062FY2026
36C24526N0724245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,874FY2026
36C24526N0622245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,874FY2026
36C25026N0416250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$617,297FY2026
36C24526N0566245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,874FY2026

Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24226P0942PRIORITY HEALTHCARE DISTRIBUTION INC242-NETWORK CONTRACT OFFICE 02 (36C242)$15,746FY2026
36C24226P0910THERACOM, L.L.C.242-NETWORK CONTRACT OFFICE 02 (36C242)$39,143FY2026
36C24226P0901COVERMYMEDS PHARMACY LLC242-NETWORK CONTRACT OFFICE 02 (36C242)$16,331FY2026
36C24226P0895CARDINAL HEALTH 108, LLC242-NETWORK CONTRACT OFFICE 02 (36C242)$31,219FY2026
36C24226P0900COVERMYMEDS PHARMACY LLC242-NETWORK CONTRACT OFFICE 02 (36C242)$11,315FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24226N0216_3600_36F79720D0180_3600 · retrieved 2026-09-26.